---
title: Drosophila as an Animal Model To Determine the Functional and Behavioral Significance
  of Dopamine Transporter Genetic Variations Associated with Brain Disorders.**DOI:**
  10.1007/978-3-031-96364-3_9
authors:
- Samuel JMabry
- Angela MCarter
- AurelioGalli
journal: Advances in neurobiology
doi: 10.1007/978-3-031-96364-3_9
publication_date: ''
source: Processed from scraped content
processing_date: '2025-10-21T22:15:09.260137'
content_type: research_paper
conditions:
- adhd
- asd
- related_disorders
topics:
- neurochemistry
categories:
- adhd
- asd
- related-disorders
- neurochemistry
reading_level: academic
audience:
- professional
- researcher
patient_friendly: false
search_priority: standard
keywords:
- behavioral
- genetic
search_tags:
- asd
- adhd
- related_disorders
- peer-reviewed
- academic
- research
- neurochemistry
---

# Drosophila as an Animal Model To Determine the Functional and Behavioral Significance of Dopamine Transporter Genetic Variations Associated with Brain Disorders.**DOI:** 10.1007/978-3-031-96364-3_9

**Authors:** Samuel JMabry, Angela MCarter, AurelioGalli

**Journal:** Advances in neurobiology

**DOI:** 10.1007/978-3-031-96364-3_9

## Abstract

Drosophila melanogaster, commonly referred to as the "fruit fly," has been a long-utilized animal model in multiple areas of biological research. It is estimated that 75% of human genes, which are associated with disease, have homologues in Drosophila. The conservation of biological systems, the genetic tractability, short generation time, and a broad array of available behavioral assessments make Drosophila an especially robust model organism for neuroscience investigations. The dopamine (DA) system, in particular, is highly conserved between mammals and Drosophila. Mutations of the DA transporter (DAT), a negative regulator of DA neurotransmission, have been associated with multiple different neuropsychiatric and neurodegenerative disorders, including autism spectrum disorders (ASDs), attention deficit hyperactivity disorder (ADHD), and Parkinson's disease (PD). Utilization of Drosophila models demonstrates specific structural and functional alterations in mutated DAT that manifest as unique behavioral phenotypes. Ultimately, combining techniques ranging from biochemistry, electrochemistry, and complex behavioral analyses facilitated a deeper understanding of how transporter function and dysfunction can translate to neurological and neuropsychiatric disorders.

**Date:** 2025-10-06
**Category:** adhd
**Source:** pubmed
**Scraped at:** 2025-10-21T11:01:21.508754
**Source URL:** https://doi.org/10.1007/978-3-031-96364-3_9## AbstractDrosophila melanogaster, commonly referred to as the "fruit fly," has been a long-utilized animal model in multiple areas of biological research. It is estimated that 75% of human genes, which are associated with disease, have homologues in Drosophila. The conservation of biological systems, the genetic tractability, short generation time, and a broad array of available behavioral assessments make Drosophila an especially robust model organism for neuroscience investigations. The dopamine (DA) system, in particular, is highly conserved between mammals and Drosophila. Mutations of the DA transporter (DAT), a negative regulator of DA neurotransmission, have been associated with multiple different neuropsychiatric and neurodegenerative disorders, including autism spectrum disorders (ASDs), attention deficit hyperactivity disorder (ADHD), and Parkinson's disease (PD). Utilization of Drosophila models demonstrates specific structural and functional alterations in mutated DAT that manifest as unique behavioral phenotypes. Ultimately, combining techniques ranging from biochemistry, electrochemistry, and complex behavioral analyses facilitated a deeper understanding of how transporter function and dysfunction can translate to neurological and neuropsychiatric disorders.## Full Text ContentSamuel J. Mabry3na1,Angela M. Carter3,4na1&Aurelio Galli3,4na1Part of the book series:Advances in Neurobiology((NEUROBIOL,volume 46))123Accesses1AltmetricAbstractDrosophila melanogaster,commonly referred to as the “fruit fly,” has been a long-utilized animal model in multiple areas of biological research. It is estimated that 75% of human genes, which are associated with disease, have homologues inDrosophila. The conservation of biological systems, the genetic tractability, short generation time, and a broad array of available behavioral assessments makeDrosophilaan especially robust model organism for neuroscience investigations. The dopamine (DA) system, in particular, is highly conserved between mammals andDrosophila. Mutations of the DA transporter (DAT), a negative regulator of DA neurotransmission, have been associated with multiple different neuropsychiatric and neurodegenerative disorders, including autism spectrum disorders (ASDs), attention deficit hyperactivity disorder (ADHD), and Parkinson’s disease (PD). Utilization ofDrosophilamodels demonstrates specific structural and functional alterations in mutated DAT that manifest as unique behavioral phenotypes. Ultimately, combining techniques ranging from biochemistry, electrochemistry, and complex behavioral analyses facilitated a deeper understanding of how transporter function and dysfunction can translate to neurological and neuropsychiatric disorders.This is a preview of subscription content,log in via an institutionto check access.Access this chapterLog in via an institutionSubscribe and saveSpringer+from $39.99 /MonthStarting from 10 chapters or articles per monthAccess and download chapters and articles from more than 300k books and 2,500 journalsCancel anytimeView plansBuy NowChapterUSD 29.95Price excludes VAT (USA)Available as PDFRead on any deviceInstant downloadOwn it foreverBuy ChaptereBookUSD 169.00Price excludes VAT (USA)Available as EPUB and PDFRead on any deviceInstant downloadOwn it foreverBuy eBookHardcover BookUSD 219.99Price excludes VAT (USA)Durable hardcover editionDispatched in 3 to 5 business daysFree shipping worldwide -see infoBuy Hardcover BookTax calculation will be finalised at checkoutPurchases are for personal use onlyInstitutional subscriptionsExplore related subjectsDiscover the latest articles, books and news in related subjects, suggested using machine learning.Behavioral GeneticsDevelopmental DisabilitiesDrosophilaHuntington's diseaseModel InvertebratesTransporters in the nervous systemReferencesBellen HJ, Tong C, Tsuda H (2010) 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nat Rev Neurosci 11:514–522.https://doi.org/10.1038/nrn2839ArticleCASPubMedPubMed CentralGoogle ScholarUgur B, Chen K, Bellen HJ (2016) Drosophila tools and assays for the study of human diseases. Dis Model Mech 9:235–244.https://doi.org/10.1242/dmm.023762ArticleCASPubMedPubMed CentralGoogle ScholarYamamoto S, Seto ES (2014) Dopamine dynamics and signaling in Drosophila: an overview of genes, drugs and behavioral paradigms. Exp Anim 63:107–119.https://doi.org/10.1538/expanim.63.107ArticleCASPubMedPubMed CentralGoogle ScholarYamamoto K, Vernier P (2011) The evolution of dopamine systems in chordates. Front Neuroanat 5:21.https://doi.org/10.3389/fnana.2011.00021ArticleCASPubMedPubMed CentralGoogle ScholarGiros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606–612ArticleCASPubMedGoogle ScholarPendleton RG, Rasheed A, Sardina T, Tully T, Hillman R (2002) Effects of tyrosine hydroxylase mutants on locomotor activity in Drosophila: a study in functional genomics. Behav Genet 32:89–94ArticlePubMedGoogle ScholarHamilton PJ, Belovich AN, Khelashvili G, Saunders C, Erreger K, Javitch JA, Sitte HH, Weinstein H, Matthies HJ, Galli A (2014) PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein. Nat Chem Biol 10:582–589.https://doi.org/10.1038/nchembio.1545ArticleCASPubMedPubMed CentralGoogle ScholarZhang SX, Rogulja D, Crickmore MA (2016) Dopaminergic circuitry underlying mating drive. Neuron 91:168–181.https://doi.org/10.1016/j.neuron.2016.05.020ArticleCASPubMedGoogle ScholarZhang K, Guo JZ, Peng Y, Xi W, Guo A (2007) Dopamine-mushroom body circuit regulates saliency-based decision-making in Drosophila. Science (New York, NY) 316:1901–1904.https://doi.org/10.1126/science.1137357ArticleCASGoogle ScholarScaplen KM, Kaun KR (2016) Reward from bugs to bipeds: a comparative approach to understanding how reward circuits function. J Neurogenet 30:133–148.https://doi.org/10.1080/01677063.2016.1180385ArticlePubMedPubMed CentralGoogle ScholarKume K, Kume S, Park SK, Hirsh J, Jackson FR (2005) Dopamine is a regulator of arousal in the fruit fly. J Neurosci 25:7377–7384. [pii].https://doi.org/10.1523/JNEUROSCI.2048-05.2005ArticleCASPubMedPubMed CentralGoogle ScholarAltschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410.https://doi.org/10.1016/s0022-2836(05)80360-2ArticleCASPubMedGoogle ScholarGiros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42:383–390ArticleCASPubMedGoogle ScholarPenmatsa A, Wang KH, Gouaux E (2013) X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503:85–90.https://doi.org/10.1038/nature12533ArticleCASPubMedPubMed CentralGoogle ScholarGiros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43–49ArticleCASPubMedGoogle ScholarBelovich AN, Aguilar JI, Mabry SJ, Cheng MH, Zanella D, Hamilton PJ, Stanislowski DJ, Shekar A, Foster JD, Bahar I et al (2019) A network of phosphatidylinositol (4,5)-bisphosphate (PIP2) binding sites on the dopamine transporter regulates amphetamine behavior in Drosophila melanogaster. Mol Psychiatry 26:4417.https://doi.org/10.1038/s41380-019-0620-0ArticleCASPubMedPubMed CentralGoogle ScholarBusson D, Pret AM (2007) GAL4/UAS targeted gene expression for studying Drosophila hedgehog signaling. Methods Mol Biol 397:161–201.https://doi.org/10.1007/978-1-59745-516-9_13ArticleCASPubMedGoogle ScholarAguilar JI, Cheng MH, Font J, Schwartz AC, Ledwitch K, Duran A, Mabry SJ, Belovich AN, Zhu Y, Carter AM et al (2021) Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-dystonia. elife 10:e68039.https://doi.org/10.7554/eLife.68039ArticleCASPubMedPubMed CentralGoogle ScholarKlein Herenbrink C, Støier JF, Reith WD, Dagra A, Gregorek MAC, Cola RB, Patriarchi T, Li Y, Tian L, Gether U et al (2022) Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors. Commun Biol 5:578.https://doi.org/10.1038/s42003-022-03488-5ArticleCASPubMedPubMed CentralGoogle ScholarAguilar JI, Dunn M, Mingote S, Karam CS, Farino ZJ, Sonders MS, Choi SJ, Grygoruk A, Zhang Y, Cela C et al (2017) Neuronal depolarization drives increased dopamine synaptic vesicle loading via VGLUT. Neuron 95:1074–1088. e1077.https://doi.org/10.1016/j.neuron.2017.07.038ArticleCASPubMedPubMed CentralGoogle ScholarShekar A, Mabry SJ, Cheng MH, Aguilar JI, Patel S, Zanella D, Saleeby DP, Zhu Y, Romanazzi T, Ulery-Reynolds P et al (2023) Syntaxin 1 Ser14 phosphorylation is required for nonvesicular dopamine release. Sci Adv 9:eadd8417.https://doi.org/10.1126/sciadv.add8417ArticlePubMedPubMed CentralGoogle ScholarRahbek-Clemmensen T, Lycas MD, Erlendsson S, Eriksen J, Apuschkin M, Vilhardt F, Jørgensen TN, Hansen FH, Gether U (2017) Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains. Nat Commun 8:740.https://doi.org/10.1038/s41467-017-00790-3ArticleCASPubMedPubMed CentralGoogle ScholarLycas MD, Ejdrup AL, Sørensen AT, Haahr NO, Jørgensen SH, Guthrie DA, Støier JF, Werner C, Newman AH, Sauer M et al (2022) Nanoscopic dopamine transporter distribution and conformation are inversely regulated by excitatory drive and D2 autoreceptor activity. Cell Rep 40:111431.https://doi.org/10.1016/j.celrep.2022.111431ArticleCASPubMedPubMed CentralGoogle ScholarSun F, Zeng J, Jing M, Zhou J, Feng J, Owen SF, Luo Y, Li F, Wang H, Yamaguchi T et al (2018) A genetically encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice. Cell 174:481–496. e419.https://doi.org/10.1016/j.cell.2018.06.042ArticleCASPubMedPubMed CentralGoogle ScholarReith MEA, Kortagere S, Wiers CE, Sun H, Kurian MA, Galli A, Volkow ND, Lin Z (2022) The dopamine transporter gene SLC6A3: multidisease risks. Mol Psychiatry 27:1031–1046.https://doi.org/10.1038/s41380-021-01341-5ArticleCASPubMedGoogle ScholarHamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, Belovich AN, Sahai MA, Cook EH, Gether U et al (2013) De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry 18:1315–1323.https://doi.org/10.1038/mp.2013.102ArticleCASPubMedPubMed CentralGoogle ScholarDiCarlo GE, Mabry SJ, Cao X, McMillan C, Woynaroski TG, Harrison FE, Reddy IA, Matthies HJG, Flynn CR, Wallace MT et al (2021) Autism-associated variant in the SLC6A3 gene alters the oral microbiome and metabolism in a murine model. Front Psych 12:655451.https://doi.org/10.3389/fpsyt.2021.655451ArticleGoogle ScholarCampbell NG, Shekar A, Aguilar JI, Peng D, Navratna V, Yang D, Morley AN, Duran AM, Galli G, O’Grady B et al (2019) Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in SLC6A3. Proc Natl Acad Sci USA 116:3853–3862.https://doi.org/10.1073/pnas.1816247116ArticleCASPubMedPubMed CentralGoogle ScholarMazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD (2008) Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci 28:7040–7046. [pii].https://doi.org/10.1523/JNEUROSCI.0473-08.2008ArticleCASPubMedPubMed CentralGoogle ScholarReith MEA, Jones KT, Zhen J, Topiol S (2018) Latch and trigger role for R445 in DAT transport explains molecular basis of DTDS. Bioorg Med Chem Lett 28:470–475.https://doi.org/10.1016/j.bmcl.2017.12.016ArticleCASPubMedGoogle ScholarBowton E, Saunders C, Erreger K, Sakrikar D, Matthies HJ, Sen N, Jessen T, Colbran RJ, Caron MG, Javitch JA et al (2010) Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci 30:6048–6057. [pii].https://doi.org/10.1523/JNEUROSCI.5094-09.2010ArticleCASPubMedPubMed CentralGoogle ScholarDiCarlo GE, Aguilar JI, Matthies HJ, Harrison FE, Bundschuh KE, West A, Hashemi P, Herborg F, Rickhag M, Chen H et al (2019) Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors. J Clin Invest 129:130.https://doi.org/10.1172/JCI127411ArticleGoogle ScholarAmerican Psychiatric Association. 5th edn. Washington; 2013Google ScholarSanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL et al (2012) De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485:237–241.https://doi.org/10.1038/nature10945ArticleCASPubMedPubMed CentralGoogle ScholarAnderson BM, Schnetz-Boutaud N, Bartlett J, Wright HH, Abramson RK, Cuccaro ML, Gilbert JR, Pericak-Vance MA, Haines JL (2008) Examination of association to autism of common genetic variationin genes related to dopamine. Autism Res 1:364–369.https://doi.org/10.1002/aur.55ArticleCASPubMedPubMed CentralGoogle ScholarKohls G, Chevallier C, Troiani V, Schultz RT (2012) Social ‘wanting’ dysfunction in autism: neurobiological underpinnings and treatment implications. J Neurodev Disord 4:10.https://doi.org/10.1186/1866-1955-4-10ArticlePubMedPubMed CentralGoogle ScholarNeale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin CF, Stevens C, Wang LS, Makarov V et al (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485:242–245.https://doi.org/10.1038/nature11011ArticleCASPubMedPubMed CentralGoogle ScholarO'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD et al (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485:246–250.https://doi.org/10.1038/nature10989ArticleCASPubMedPubMed CentralGoogle ScholarIossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, Lee YH, Narzisi G, Leotta A et al (2012) De novo gene disruptions in children on the autistic spectrum. Neuron 74:285–299.https://doi.org/10.1016/j.neuron.2012.04.009ArticleCASPubMedPubMed CentralGoogle ScholarYamashita A, Singh SK, Kawate T, Jin Y, Gouaux E (2005) Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature 437:215–223.https://doi.org/10.1038/nature03978ArticleCASPubMedGoogle ScholarPrisinzano T, Rice CK, Baumann HM, Rothman BR (2004) Development of neurochemical normalization (“agonist substitution”) therapeutics for stimulant abuse: focus on the dopamine uptake inhibitor, GBR12909. Curr Med Chem Cent Nerv Syst Agents 4:47–59.https://doi.org/10.2174/1568015043477630ArticleCASGoogle ScholarLondei T, Valentini AM, Leone VG (1998) Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour. Behav Brain Res 94:249–254.https://doi.org/10.1016/s0166-4328(97)00162-9ArticleCASPubMedGoogle ScholarCheng MH, Bahar I (2015) Molecular mechanism of dopamine transport by human dopamine transporter. Structure 23:2171–2181.https://doi.org/10.1016/j.str.2015.09.001ArticleCASPubMedPubMed CentralGoogle ScholarChang HY, Grygoruk A, Brooks ES, Ackerson LC, Maidment NT, Bainton RJ, Krantz DE (2006) Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine. Mol Psychiatry 11:99–113.https://doi.org/10.1038/sj.mp.4001742ArticleCASPubMedGoogle ScholarLeDoux J (2003) The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23:727–738.https://doi.org/10.1023/a:1025048802629ArticlePubMedPubMed CentralGoogle ScholarSteimer T (2002) The biology of fear- and anxiety-related behaviors. Dialogues Clin Neurosci 4:231–249.https://doi.org/10.31887/DCNS.2002.4.3/tsteimerArticlePubMedPubMed CentralGoogle ScholarLee SH, Pak HK, Chon TS (2006) Dynamics of prey-flock escaping behavior in response to predator's attack. J Theor Biol 240:250–259.https://doi.org/10.1016/j.jtbi.2005.09.009ArticlePubMedGoogle ScholarChai C, Lim KL (2013) Genetic insights into sporadic Parkinson’s disease pathogenesis. Curr Genomics 14:486–501.https://doi.org/10.2174/1389202914666131210195808ArticleCASPubMedPubMed CentralGoogle ScholarLill CM (2016) Genetics of Parkinson’s disease. Mol Cell Probes 30:386–396.https://doi.org/10.1016/j.mcp.2016.11.001ArticleCASPubMedGoogle ScholarHerborg F, Jensen KL, Tolstoy S, Arends NV, Posselt LP, Shekar A, Aguilar JI, Lund VK, Erreger K, Rickhag M et al (2021) Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease. JCI Insight 6:6.https://doi.org/10.1172/jci.insight.151496ArticleGoogle ScholarTrinh J, Farrer M (2013) Advances in the genetics of Parkinson disease. Nat Rev Neurol 9:445–454.https://doi.org/10.1038/nrneurol.2013.132ArticleCASPubMedGoogle ScholarKurian MA, Gissen P, Smith M, Heales S Jr, Clayton PT (2011) The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol 10:721–733.https://doi.org/10.1016/s1474-4422(11)70141-7ArticleCASPubMedGoogle ScholarNg J, Zhen J, Meyer E, Erreger K, Li Y, Kakar N, Ahmad J, Thiele H, Kubisch C, Rider NL et al (2014) Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain 137:1107–1119.https://doi.org/10.1093/brain/awu022ArticlePubMedPubMed CentralGoogle ScholarBeerepoot P, Lam VM, Salahpour A (2016) Pharmacological chaperones of the dopamine transporter rescue dopamine transporter deficiency syndrome mutations in heterologous cells. J Biol Chem 291:22053–22062.https://doi.org/10.1074/jbc.M116.749119ArticleCASPubMedPubMed CentralGoogle ScholarAsjad HMM, Kasture A, El-Kasaby A, Sackel M, Hummel T, Freissmuth M, Sucic S (2017) Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism. J Biol Chem 292:19250–19265.https://doi.org/10.1074/jbc.M117.797092ArticlePubMedPubMed CentralGoogle ScholarBarone MC, Sykiotis GP, Bohmann D (2011) Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson’s disease. Dis Model Mech 4:701–707.https://doi.org/10.1242/dmm.007575ArticleCASPubMedPubMed CentralGoogle ScholarCackovic J, Gutierrez-Luke S, Call GB, Juba A, O'Brien S, Jun CH, Buhlman LM (2018) Vulnerable Parkin loss-of-function Drosophila dopaminergic neurons have advanced mitochondrial aging, mitochondrial network loss and transiently reduced autophagosome recruitment. Front Cell Neurosci 12:39.https://doi.org/10.3389/fncel.2018.00039ArticleCASPubMedPubMed CentralGoogle ScholarTrinh K, Moore K, Wes PD, Muchowski PJ, Dey J, Andrews L, Pallanck LJ (2008) Induction of the phase II detoxification pathway suppresses neuron loss in drosophila models of Parkinson’s disease. J Neurosci 28:465–472.https://doi.org/10.1523/jneurosci.4778-07.2008ArticleCASPubMedPubMed CentralGoogle ScholarFord CP (2014) The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 282:13–22.https://doi.org/10.1016/j.neuroscience.2014.01.025ArticleCASPubMedGoogle Scholarvan den Berg C, Beek PJ, Wagenaar RC, van Wieringen PC (2000) Coordination disorders in patients with Parkinson’s disease: a study of paced rhythmic forearm movements. Exp Brain Res 134:174–186.https://doi.org/10.1007/s002210000441ArticlePubMedGoogle ScholarSadaf S, Reddy OV, Sane SP, Hasan G (2015) Neural control of wing coordination in flies. Curr Biol 25:80–86.https://doi.org/10.1016/j.cub.2014.10.069ArticleCASPubMedGoogle ScholarCard G, Dickinson MH (2008) Visually mediated motor planning in the escape response of Drosophila. Curr Biol 18:1300–1307.https://doi.org/10.1016/j.cub.2008.07.094ArticleCASPubMedGoogle ScholarDaniels GM, Amara SG (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274:35794–35801ArticleCASPubMedGoogle ScholarFriggi-Grelin F, Coulom H, Meller M, Gomez D, Hirsh J, Birman S (2003) Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase. J Neurobiol 54:618–627.https://doi.org/10.1002/neu.10185ArticleCASPubMedGoogle ScholarDownload referencesFundingDevelopment of this chapter was supported by the National Institute of Drug Abuse grant RO1DA038058 (A.G.), RO1DA035263 (A.G.), R01DA056484 (A.G. and A.M.C.) and R21DA059884 (A.M.C.).Author informationAuthor notesAngela M. Carter and Aurelio Galli contributed equally with all other contributors.Authors and AffiliationsUAB Department of Surgery, Birmingham, AL, USASamuel J. Mabry, Angela M. Carter & Aurelio GalliUAB CINEMA, Birmingham, AL, USAAngela M. Carter & Aurelio GalliAuthorsSamuel J. MabryView author publicationsSearch author on:PubMedGoogle ScholarAngela M. CarterView author publicationsSearch author on:PubMedGoogle ScholarAurelio GalliView author publicationsSearch author on:PubMedGoogle ScholarCorresponding authorCorrespondence toAurelio Galli.Editor informationEditors and AffiliationsDept of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA, USAOle MortensenRights and permissionsReprints and permissionsCopyright information© 2025 The Author(s), under exclusive license to Springer Nature Switzerland AGAbout this chapterCite this chapterMabry, S.J., Carter, A., Galli, A. (2025).Drosophilaas an Animal Model To Determine the Functional and Behavioral Significance of Dopamine Transporter Genetic Variations Associated with Brain Disorders.In: Mortensen, O. (eds) Monoamine Transporters. Advances in Neurobiology, vol 46. Springer, Cham. https://doi.org/10.1007/978-3-031-96364-3_9Download citation.RIS.ENW.BIBDOI:https://doi.org/10.1007/978-3-031-96364-3_9Published:07 October 2025Publisher Name:Springer, ChamPrint ISBN:978-3-031-96363-6Online ISBN:978-3-031-96364-3eBook Packages:Biomedical and Life SciencesBiomedical and Life Sciences (R0)Share this chapterAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy shareable link to clipboardProvided by the Springer Nature SharedIt content-sharing initiativeKeywordsDrosophilaComplex behaviorDopamine transporter (DAT)Anomalous dopamine efflux (ADE)Autism spectrum disorder (ASD)Dopamine transporter deficiency syndrome (DTDS)Parkinson’s disease (PD)Publish with usPolicies and ethics---
*This content was automatically scraped by Webscraping Agent A*